2024 annual financial data
Ultragenyx Pharmaceutical 2024 Operating margin
Direct answer
Operating margin was -95.67%.
Operating income was -535,973,000 USD and net income was -569,183,000 USD.
Operating cash flow was -414,188,000 USD.
Get free Ultragenyx Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 560,230,000 USD
- Operating income
- -535,973,000 USD
- Net income
- -569,183,000 USD
- Operating cash flow
- -414,188,000 USD